Papers / Presentations |
1. Pabla N, Huang S, Mi QS, Daniel R, Dong Z: ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 2008, 283(10):6572-6583.
2. Pabla N, Dong Z: Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies (review). Kidney Int 2008,73(9):994-1007.
3. Jiang M, Pabla N, Murphy RF, Yang T, Yin XM, Degenhardt K, White E, Dong Z: Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem 2007, 282(4):2636-2645.
4. Wang J, Pabla N, Wang CY, Wang W, Schoenlein PV, Dong Z: Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53. Am J Physiol Renal Physiol 2006, 291(6):F1300-1307.
5. Bhatt K, Feng L, Pabla N, Liu K, Smith S, Dong Z: Effects of targeted Bcl-2 expression in mitochondria or endoplasmic reticulum on renal tubular cell apoptosis. Am J Physiol Renal Physiol 2008, 294(3):F499-507.
6. Jiang M, Wei Q, Pabla N, Dong G, Wang CY, Yang T, Smith SB, Dong Z: Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol 2007, 73(9):1499-1510.
7. Jiang G, Mysona B, Dun Y, Gnana-Prakasam JP, Pabla N, Li W, Dong Z, Ganapathy V, Smith SB: Expression, subcellular localization, and regulation of sigma receptor in retinal muller cells. Invest Ophthalmol Vis Sci 2006, 47(12):5576-5582.
|